Albendazole Supplier is generally regarded as harmless for children over the age of one year when used to treat parasitic infections. Nevertheless, the safety of this substance in expectant women is more intricate. The FDA has classified albendazole as a Category C drug, which indicates that there are no well-controlled studies in pregnant women and that animal studies have demonstrated potential dangers to the fetus.

It is typically avoided during the first trimester and used with caution later in pregnancy, provided that the benefits outweigh the risks. Prior to administering Albendazole to expectant women or children, it is imperative to consult with a healthcare provider.